Dermabond

Dermabond is a product family that comprises of two topical skin adhesives (Dermabond Advanced and Dermabond Mini) and one skin closure system (Dermabond Prineo).  Dermabond products focus on secure skin closure. Wound closure is critical to surgical outcomes and patient satisfaction.  The Dermabond product portfolio of topical skin adhesives is a comprehensive portfolio for a variety of clinical needs.

Dermabond products have shown to add strength to wound closures, provide a microbial barrier, inhibit some infection causing bacteria, and improve patient satisfaction.  Dermabond is the only topical skin adhesive that has been tried, tested, and trusted for nearly 20 years.  Dermabond Advanced is supported by more randomized controlled trials than the alternative top 6 topical skin adhesives combined.* Dermabond Prineo is a powerful and effective combination of 2-octyl cyanoacrylate and self-adhering mesh. The unique Dermabond formulas are protected by over 8 US Patents. 

Dermabond is made by Ethicon, a Johnson & Johnson company.  Ethicon is a company with a wide range of surgical expertise.  Ethicon produces a variety of surgical products from shears, trocars, tissue sealers, hernia repair, stapplers, skin adhesives, and sutures.

Dermabond Advanced topical skin adhesive is ideal for:

• Open hernia repair
• Mid to large lacerations

Dermabond Mini topical skin adhesive is ideal for:

• Small lacerations
• Minimally invasive procedures

Dermabond Prineo Skin Closure System (22 cm) is ideal for orthopedic surgeries:

• Total knee arthroplasty
• Total hip arthroplasty
• Spine surgeries

Dermabond Prineo Skin Closure System (22 cm) was shown to be*:

• 33% stronger when compared to the average strength of staples
• 40% stronger when compared to the average strength of 4-0 suture

Dermabond Prineo Skin Closure System (60 cm) is ideal for:

• Abdominoplasty
• Breast reconstruction
• Sternotomy
• Brachioplasty

Dermabond Advanced topical skin adhesive and the Dermabond Prineo skin closure system are proven 99% effective through 72 hours in vitro against organisms commonly responsible for SSIs, including:*

• Staphylococcus epidermidis
• Staphylococcus aureus
• Escherichia coli
• Pseudomonas aeruginosa
• Enterococcus faecium

*See Dermabond Product Literature for more details and research support.

Dermabond Product Literature

• Dermabond Advanced Instructions for Use
• Dermabond Mini Instructions for Use
• Dermabond Prineo Instructions for Use
• Dermabond Advanced Brochure
• Dermabond Portfolio Brochure